Replica project results at the XVI FISV Congress in Naples

The Replica project team activity and the results of the studies on the reduced cytotoxicity and inflammation induced by cigarette smoke and ENDS aerosol will be presented during the XVI edition of the Congress of the Italian Federation of Life Sciences (FISV), which represents over 10.0000 Italian scientists and which will take place from 14 to 16 September 2022 in Naples

Continue ReadingReplica project results at the XVI FISV Congress in Naples

Quit Strong: New Zealand bets on vaping to quit smoking

QUIT STRONG is one of the first public health initiatives in the World that embrace THR (Tobacco Harm Reduction), showing openness to strategies that can support smokers during smoking cessation programmes. Low risk products allow to provide the necessary amount of nicotine while maintaining the behavioral and psychological rituals associated to smoking

Continue ReadingQuit Strong: New Zealand bets on vaping to quit smoking

The road ahead for substitution of combustible cigarettes with low risk technologies as a strategy to reduce harm in the 21st Century

The article highlights why harm reduction is important, what are the ways to achieve harm reduction, particularly the use of snus, heated tobacco products and e-cigarettes and what are the barriers to use of such alternatives. This article is not a systematic or narrative review; it is an overview of recent studies on these products or devices. Industry conducted or funded studies were excluded from the review.

Continue ReadingThe road ahead for substitution of combustible cigarettes with low risk technologies as a strategy to reduce harm in the 21st Century